➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Colorcon
McKesson
McKinsey
Express Scripts

Last Updated: August 3, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MARCAINE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Marcaine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00180687 Clinical Trial of the Use of Intraperitoneal Local Anaesthetic Completed Imperial College London Phase 3 2004-10-01 Patients undergoing keyhole gall bladder removal will be divided into 3 groups, one control, one will have local anaesthetic and the third will have normal saline nebulised into their abdomen before closure of the wounds to reduce postoperative pain. These medications will be given on top of the standard pain management protocol.
NCT00472134 Laparoscopic Ventral Hernia Repair With Elastomeric Pain Pump Completed University Hospitals Cleveland Medical Center N/A 2005-12-01 The purpose of this study is to determine the effects of a local anesthetic dispensed via a tiny catheter device, called the ON-Q PainBuster pump, placed during surgery on top of the mesh used in the laparoscopic repair of ventral hernias. The goals are: - reducing postoperative pain from this procedure - decreasing length of hospital stay - reducing or eliminating amount of post-operative narcotics used
NCT00508066 Continuous Local Infusion of Anesthetic at the Incisional Site for Scoliosis Surgery Completed Shriners Hospitals for Children Phase 4 2007-05-01 The purpose of this study is to evaluate the effects of continuous local anesthetic delivery on the immediate post-op recovery of patients undergoing spinal fusion surgery for congenital or idiopathic scoliosis.
NCT00508976 Clinical Proposal for the Comparison of Intraperitoneal Anesthetic to Injected Local Anesthetic Completed Pinnacle Health System Phase 2 2007-06-01 The purpose of this study is to determine if pre-incisional lidocaine injection, instilled liquid bupivacaine, intra-abdominal aerosolized bupivacaine, or post-operative bupivacaine injection is superior in post-operative pain control in laparoscopic bariatric surgical patients.
NCT00532662 Postoperative Analgesia by Epidural vs IV Ketamine Concurrent With Caudal Anesthesia in Pediatric Orthopedic Surgery Unknown status Tehran University of Medical Sciences Phase 4 2007-11-01 Preemptive analgesia can improve postoperative pain management. Ketamine may prevent central sensitization during surgery and result in preemptive analgesia. The purpose of this study is to examine the effectiveness of ketamine as a preemptive analgesic as previous studies have shown the involvement of N-methyl-D-Aspartate (NMDA) receptor in neuroplasticity.
NCT00574015 The Comparison of Supraperiosteal Nerve Block With Opiate Analgesia in Alleviating the Pain of Toothache Completed Albany Medical College Phase 4 2007-12-01 This study will compare the degree of pain control provided by two techniques for persons with toothache in an emergency department. The two techniques include; - standard oral narcotic pain medication - numbing the tooth with local anesthetic by needle injection
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Marcaine Hydrochloride

Condition Name

Condition Name for Marcaine Hydrochloride
Intervention Trials
Pain, Postoperative 26
Pain 23
Postoperative Pain 20
Cesarean Section Complications 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Marcaine Hydrochloride
Intervention Trials
Pain, Postoperative 70
Fractures, Bone 7
Hernia 6
Labor Pain 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Marcaine Hydrochloride

Trials by Country

Trials by Country for Marcaine Hydrochloride
Location Trials
United States 115
Egypt 18
Canada 14
Turkey 13
Belgium 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Marcaine Hydrochloride
Location Trials
California 14
Ohio 9
Pennsylvania 8
Florida 7
Georgia 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Marcaine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Marcaine Hydrochloride
Clinical Trial Phase Trials
Phase 4 82
Phase 3 17
Phase 2/Phase 3 4
[disabled in preview] 37
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Marcaine Hydrochloride
Clinical Trial Phase Trials
Completed 68
Recruiting 54
Not yet recruiting 47
[disabled in preview] 28
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Marcaine Hydrochloride

Sponsor Name

Sponsor Name for Marcaine Hydrochloride
Sponsor Trials
Cairo University 9
Samuel Lunenfeld Research Institute, Mount Sinai Hospital 6
Assiut University 6
[disabled in preview] 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Marcaine Hydrochloride
Sponsor Trials
Other 250
Industry 12
U.S. Fed 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
AstraZeneca
Johnson and Johnson
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.